Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 9;12(7):924.
doi: 10.3390/pathogens12070924.

From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications

Marta Rosas Cancio-Suárez  1   2   3   4 , Jorge Díaz-Álvarez  1   2   3 , Raquel Ron  1   2   3 , Javier Martínez-Sanz  1   2   3 , Sergio Serrano-Villar  1   2   3 , Santiago Moreno  1   2   3   4 , Matilde Sánchez-Conde  1   2   3
Affiliations
Review

From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications

Marta Rosas Cancio-Suárez et al. Pathogens. .

Abstract

Pre-exposure prophylaxis (PrEP) is a highly effective HIV-prevention strategy that involves the continuous administration of antiretroviral drugs to HIV-negative individuals with a substantial risk of contracting an HIV infection. The use of PrEP has shown a reduction in the risk of HIV acquisition through sexual intercourse by up to 99%. Despite its effectiveness, PrEP uptake remains low among populations at high risk of HIV infection. This highlights the need for further research in strategies to enhance awareness and uptake of PrEP amongst these specific populations. This article presents a comprehensive overview of the existing literature on the effectiveness of PrEP in reducing HIV transmission rates. Additionally, we examine the obstacles related to PrEP implementation and uptake and put forward potential strategies to raise awareness and improve its use among populations at an increased risk of contracting HIV.

Keywords: HIV; pre-exposure prophylaxis; prevention strategies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Global HIV & AIDS Statistics—Fact Sheet. (s/f). Unaids.org. [(accessed on 2 May 2023)]. Available online: https://www.unaids.org/en/resources/fact-sheet.
    1. World Health Organization HIV and AIDS. [(accessed on 19 April 2023)]; Available online: https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids.
    1. The European Centre for Disease Prevention and Control (ECDC) WHO Regional Office for Europe . HIV/AIDS Surveillance in Europe 2022–2021 Data. WHO Regional Office for Europe; København, Denmark: 2022. - DOI
    1. Unidad de Vigilancia de VIH, ITS y Hepatitis . Vigilancia Epidemiológica del VIH y sida en España 2021: Sistema de Información Sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Centro Nacional de Epidemiología; Instituto de Salud Carlos III/ División de Control de VIH, ITS, Hepatitis Virales y Tuberculosis; Ministerio de Sanidad; Madrid, Spain: 2022.
    1. Grant R.M., Anderson P.L., McMahan V., Liu A., Amico K.R., Mehrotra M., Hosek S., Mosquera C., Casapia M., Montoya O., et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. Lancet Infect. Dis. 2014;14:820–829. doi: 10.1016/S1473-3099(14)70847-3. - DOI - PMC - PubMed

LinkOut - more resources